1. Bennett JC, Plum F, eds. Cecil textbook of medicine. Philadelphia, PA: WB Saunders. 1996: p 1459–1466 

2. Tierney LM, McPhee SJ, Papadakis MA, eds. Current medical diagnosis and treatment. Los Altos, CA: Lange Medical. 1997: p 161 

3. Smith MD, Gibson RA, Brooks PM. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheum 1985; 12: 299–305 

4. Zaphiropoulos GC. Rheumatoid arthritis and the gut. Br J Rheum 1986; 25: 138–140 

5. Segal AW, Isenberg DA, Hajirousou V et al. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis. Br J Rheum 1986; 25: 162–166 

6. Ebringer A, Khalapfour S, Wilson C. Rheumatoid arthritis and Proteus. A possible aetiological association. Rheumatol Int 1989; 9: 223–228 

7. Ebringer A, Cox N, Abuljadayel AI et al. Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis. Br J Rheum 1988; 2772–2785 

8. Henriksson AE, Blomquist L, Nord CE et al. Small intestinal bacterial overgrowth in patients with rheumatoid arthritis. Annals Rheumatic Dis 1993; 52: 503–510 

9. Philips PE. Seminars in arthritis and rheumatism. Infectious agents in the pathogenesis of rheumatoid arthritis. Semin Arthr Rheum 1986; 16: 1–100 

10. Venables P. Epstein–Barr virus infection and autoimmunity in rheumatoid arthritis. Ann Rheum Dis 1988; 47: 265–269 

11. Clark HW, Coker-Vann MR, Bailey JS, Brown TM. Detection of mycoplasmal antigens in immune complexes from rheumatoid arthritis synovial fluids. Ann Allergy 1988; 60: 394–398 

12. Wyburn-Mason R. The naeglerial causation of rheumatoid disease and many human cancers. A new concept in medicine. Med Hypotheses. 1979; 5: 1237–1249 

13. Hall GM, Spector TD. Depressed levels of dehydroepiandro-sterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Annals Rheum Dis 1993; 52: 211–214 

14. van Vollenhoven RF et al. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1305–1310 

15. van Vollenhoven R, Engleman EG, McGuire JL. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthr Rheum 1995; 38: 1826–1831 

16. Clegg DO, Ward JR. Diagnostic criteria in rheumatoid arthritis. Scand J Rheum 1987; 65: 3–11 

17. Nishiya K, Matsueda H, Shirakami T et al. Serum and urinary ferritin levels in patients with rheumatoid arthritis. Acta Med Okayama 1985; 39: 321–328 

18. Jenkins R, Rooney P, Jones D et al. Increased intestinal permeability in patients with rheumatoid arthritis. A side effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheum 1987; 26:103–107 

19. Fries JF et al. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterol 1989; 96: 647–655 

20. Scott DL, Symmons DP, Coulton BL et al. Long-term outcome of treating rheumatoid arthritis. Results after 20 years. Lancet 1989; i: 1108–1111 

21. Trowell H, Burkitt D. Western diseases: their emergence and prevention. Cambridge, MA: Harvard University Press. 1981 

22. Darlington LG, Ramsey NW. Clinical review. Review of dietary therapy for rheumatoid arthritis. Br J Rheumatol 1993; 32: 507–514 

23. Buchanan HM, Preston SJ, Brooks PM et al. Is diet important in rheumatoid arthritis. Br J Rheumatol 1991; 30: 125–134 

24. McCrae F, Veerapen K, Dieppe P. Diet and arthritis. Practitioner 1986; 230: 359–361 

25. Darlington LG, Ramsey NW, Mansfield JR. Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet 1986; i: 236–238 

26. Hicklin JA, McEwen LM, Morgan JE. The effect of diet in rheumatoid arthritis. Clinical Allergy 1980; 10: 463–46727. Panush RS. Delayed reactions to foods. Food allergy and rheumatic disease. Annals of Allergy 1986; 56: 500–503 

28. Van de Laar MAFJ, Ander Korst JK. Food intolerance in rheumatoid arthritis. I. A double-blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Annals Rheum Dis  1992; 51: 298–302 

29. Kjeldsen-Kragh J et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991; 338: 899–902 

30. Skoldstam L, Larsson L, Lindstrom FD. Effects of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol 1979; 8: 249–255 

31. Kroker GF, Stroud RM, Marshall R et al. Fasting and rheumatoid arthritis. A multicenter study. Clinical Ecology 1984; 2: 137–144 

32. Hafstrom I, Ringertz B, Gyllenhammar H et al. Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthr Rheum 1988; 31: 585–592 

33. Kjeldsen-Kragh J et al. Vegetarian diet for patients with rheumatoid arthritis - Status. Two years after introduction of the diet. Clin Rheumatol 1994; 13: 475–482 

34. Peltonen R, Kjeldsen-Kvagh J et al. Changes in faecal flora in rheumatoid arthritis during fasting and one-year vegetarian diet. Br J Rheumatol 1994; 33: 638–643 

35. Peltonen R, Nenonen M, Helve T et al. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Br J Rheumatol 1997; 36: 64–68 

36. De Witte TJ, Geerdink PJ, Lamers CB et al. Hypochlorhydria and hypergastrinemia in rheumatoid arthritis. Ann Rheumatic Dis 1979; 38: 14–17 

37. Henriksson K, Uvnas-Moberg K, Nord CE et al. Gastrin, gastric acid secretion, and gastric microflora in patients with rheumatoid arthritis. Ann Rheumatic Dis 1986; 45: 475–483

38. Horger I. Enzyme therapy in multiple rheumatic diseases. Therapiewoche 1983; 33: 3948–3957 

39. Ransberger K. Enzyme treatment of immune complex diseases. Arthr Rheum 1986; 8: 16–19 

40. Shapiro JA, Koepsell TD, Voigt LF et al. Diet and rheumatoid arthritis in women. A possible protective effect of fish consumption. Epidemiology 1996; 7: 256–263 

41. Jantti J, Nikkari T, Solakivi T et al. Evening primrose oil in rheumatoid arthritis. Changes in serum lipids and fatty acids. Ann Rheum Dis 1989; 48: 124–127 

42. Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol 1991; 30: 371–372 

43. Belch JJ, Ansell D, Madhok R et al. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis. A double blind placebo controlled study. Ann Rheum Dis 1988; 47: 96–104 

44. Levanthal LJ et al. Treatment of rheumatoid arthritis with gammalinoleic acid. Annals Int Med 1993; 119: 867–873 

45. Kremer J, Michaelek AV, Lininger L et al. Effects of manipulation of dietary fatty acids on clinical manifestation of rheumatoid arthritis. Lancet 1985; i: 184–187 

46. Kremer J, Jubiz W, Michalek A et al. Fish-oil supplementation in active rheumatoid arthritis: a double-blinded, controlled cross-over study. Ann Intern Med 1987; 106: 497–502 

47. Sperling R, Weinblatt M, Robin JL et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 1987; 30: 988–997 

48. Clelend LG, French JK, Betts WH et al. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988; 15: 1471–1475 

49. Magaro M, Altmonte L, Zoli A et al. Influence of diet with different lipid composition on neutrophil composition on neutrophil chemiluminescence and disease activity in patients with rheumatoid arthritis. Ann Rheum Dis 1988; 47: 793–796 

50. van der Tempel H, Tulleken JE, Limburg PC et al. Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 1990; 49: 76–80 

51. Kremer JM, Lawrence DA, Jubiz W et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arth Rheum 1990; 33: 810–820 

52. Lau CS, Gallacher C, Ross P et al. Maxepa on nonsteroidal anti-inflammatory drug usage in patients with mild rheumatoid arthritis. Br J Rheumatol 1991; 30: 137 

53. Nielsen GL, Faarvang KL, Thomsen BS et al. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis. A randomized, double-blind trial. Eur J Clin Invest 1992; 22: 687–691 

54. Shukla VKS, Perkins EG. The presence of oxidative polymeric materials in encapsulated fish oils. Lipids 1991; 26: 23–26 

55. Fritshe KL, Johnston PV. Rapid autoxidation of fish oil in diets without added antioxidants. J Nutr 1988; 118: 425–426 

56. Harats D et al. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 1991; 90: 127–139 

57. Nettleton JA. Omega-3 fatty acids. Comparison of plant and seafood sources in human nutrition. J Am Diet Assoc 1991; 91: 331–337 

58. Cunnane SC et al. Alpha-linolenic acid in humans: direct functional role or dietary precursor. Nutrition 1991; 7: 437–439

59. Mantzioris E, James MJ, Gibson RA et al. Dietary substitution with alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 1994; 59: 1304–1309 

60. Kelley DS. Alpha-linolenic acid and immune response. Nutrition 1992; 8: 215–217 

61. Nordstrom DC, Honkanen VE, Nasu Y et al. Alpha-linolenic acid in the treatment of rheumatoid arthritis: a double-blind placebo-controlled and randomized study. Flaxseed vs. safflower oil. Rheumatol Int 1995; 14: 231–234 

62. Cody V, Middleton E, Harborne JB. Plant flavonoids in biology and medicine – biochemical, pharmacological, and structure-activity relationships. New York, NY: Alan R Liss. 1986; Cody V, Middleton E, Harborne JB, Beretz A. Plant flavonoids in biology and medicine II – biochemical, pharmacological, and structure activity relationships. New York, NY: Alan R Liss. 1988 

63. Comstock GW, Burke AE, Hoffman SC et al. Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupuserythematosus. Ann Rheum Dis 1997; 56: 323–325 

64. Tarp U, Overvad K, Hansen JC et al. Low selenium level in severe rheumatoid arthritis. Scandinavian Journal of Rheumatology 1985; 14: 97–101 

65. Tarp U, Overvad K, Thorling EB et al. Selenium treatment in rheumatoid arthritis. Scandinavian Journal of Rheumatology 1985; 14: 364–368 

66. Munthe E, Aseth J. Treatment of rheumatoid arthritis with selenium and vitamin E. Scandinavian Journal of Rheumatology 1984; 53: 103 

67. Pandley SP, Bhattacharya SK, Sundar S. Zinc in rheumatoid arthritis. Indian Journal of Medical Research 1985; 81: 618–620 

68. Simkin PA. Treatment of rheumatoid arthritis with oral zinc sulfate. Agents and Actions (supplement) 1981; 8: 587–595  69. Mattingly PC, Mowat AG. Zinc sulphate in rheumatoid arthritis. Ann Rheum Dis 1982; 41: 456–457 

70. Pasquier C, Mach PS, Raichvarg D et al. Manganese-containing superoxide-dismutase deficiency in polymorphonuclear leukocytes of adults with rheumatoid arthritis. Inflammation 1984; 8: 27–32 

71. Menander-Huber KB. Orgotein in the treatment of rheumatoid arthritis. Europ J Rheum Inflammation 1981; 4: 201–211 

72. Zidenberg-Cherr S, Keen CL, Lonnerdal B et al. Dietary superoxide dismutase does not affect tissue levels. Am J Clin Nutr 1983; 37: 5–7 

73. Rosa GD, Keen CL, Leach RM et al. Regulation of superoxide dismutase activity by dietary manganese. J Nutr 1980; 110: 795–804 

74. Mullen A, Wilson CWM. The metabolism of ascorbic acid in rheumatoid arthritis. Proc Nutr Sci 1976; 35: 8A–9A 

75. Subramanian N. Histamine degradation potential of ascorbic acid. Agents and Actions 1978; 8: 484–487 

76. Levine M. New concepts in the biology and biochemistry of ascorbic acid. New Engl J Med 1986; 314: 892–902 

77. Barton-Wright EC, Elliott WA. The pantothenic acid metabolism of rheumatoid arthritis. Lancet 1963; ii: 862–863 

78. General Practitioner Research Group. Practitioner 1980; 224: 208–211 

79. Sorenson JRJ, Hangarter W. Treatment of rheumatoid and degenerative disease with copper complexes. A review with emphasis on copper salicylate. Inflammation 1977; 2: 217–238 

80. Lewis AJ. The role of copper in inflammatory disorders. Agents Actions 1984; 513–519 

81. Walker WR, Keats DM. An investigation of the therapeutic value of the “copper bracelet” – dermal assimilation of copper in arthritic/rheumatoid conditions. Agents Actions 1976; 6: 454–458 

82. Chung MH, Kessner L, Chan PC. Degradation of articular cartilage by copper and hydrogen peroxide. Agents Actions 1984; 15: 328–335 

83. Sullivan MX, Hess WC. Cystine content of finger nails in arthritis. J Bone Joint Surg 1935; 16: 185–188 

84. Senturia BD. Results of treatment of chronic arthritis and rheumatoid conditions with colloidal sulphur. J Bone Joint Surg 1934; 16: 119–125 

85. Wheeldon. The use of colloidal sulphur in the treatment of arthritis. J Bone Joint Surg 1935; 17: 693–726 

86. Kaufman W. The common form of joint dysfunction: its incidence and treatment. Brattleboro, VT: E.L. Hildreth. 1949 

87. Hoffer A. Treatment of arthritis by nicotinic acid and nicotinamide. Canadian Medical Association Journal 1959; 81; 235–239 

88. Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Medica 1991; 57: 1–7 

89. Sharma OP. Antioxidant properties of curcumin and related compounds. Biochem Pharmacol 1976; 25: 1811–1825 

90. Toda S, Miyase T, Arich H et al. Natural antioxidants. Antioxidative compounds isolated from rhizome of Curcuma longa L. Chem Pharmacol Bull 1985; 33: 1725–1728 

91. Srimal R, Dhawan B. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmac 1973; 25: 447–452 

92. Srivastava R. Inhibition of neutrophil response by curcumin. Agents Actions 1989; 28: 298–303 

93. Flynn DL, Rafferty MF. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids. Inhibitory activities of curcuminoids and yakuchinones. Prost Leukotri Med 1986; 22: 357–360 

94. Deodhar SD, Sethi R, Srimal RC. Preliminary studies on antirheumatic activity of curcumin (diferuloyl methane). Ind J Med Res 1980; 71: 632–634 

95. Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol 1986; 24: 651–654 

96. Shankar TNB, Shantha NV, Ramesh HP et al. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs & monkeys. Indian J Exp Biol 1980; 18: 73–75 

97. Taussig S, Batkin S. Bromelain: the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. J Ethnopharmacol 1988; 22: 191–203 

98. Cohen A, Goldman J. Bromelain therapy in rheumatoid arthritis. Penn Med J 1964; 67: 27–30 

99. Leung A. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. New York, NY: John Wiley. 1980 

100. Kiuchi F et al. Inhibition of prostaglandin: and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 1992; 40: 387–391 

101. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) and rheumatic disorders. Med Hypothesis 1989; 29: 25–28 

102. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypothesis 1992; 39: 342–348 

103. Shimizu K, Amagaya S, Ogihara Y. Combination of shosaikoto (Chinese traditional medicine) and prednisolone on the anti-inflammatory action. J Pharmaco Dyn 1984; 7: 891–899 

104. Yamamoto M, Kumagai A, Yokoyama Y. Structure and actions of saikosaponins isolated from Bupleurum falcatum L. Arzniem Forsch. 1975; 25: 1021–1040 

105. Hiai S, Yokoyama H, Nagasawa T et al. Stimulation of the pituitary-adrenocortical axis by saikosaponin of Bupleuri radix. Chem Pharm Bull 1981; 29: 495–499 

106. Hikino H. Recent research on Oriental medicinal plants. Economic and Medicinal Plant Research 1985; 1: 53–85 

107. Sukenik S. Balneotherapy for rheumatoid arthritis at the Dead Sea. Isr Med J 1995; 31: 210–214